Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Max Wohlauer to Anticoagulants

This is a "connection" page, showing publications Max Wohlauer has written about Anticoagulants.

 
Connection Strength
 
 
 
0.281
 
  1. Attisani L, Pucci A, Luoni G, Luzzani L, Pegorer MA, Settembrini AM, Bissacco D, Wohlauer MV, Piffaretti G, Bellosta R. COVID-19 and acute limb ischemia: a systematic review. J Cardiovasc Surg (Torino). 2021 Dec; 62(6):542-547.
    View in: PubMed
    Score: 0.142
  2. Harr JN, Moore EE, Chin TL, Ghasabyan A, Gonzalez E, Wohlauer MV, Sauaia A, Banerjee A, Silliman CC. Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis. Shock. 2014 Jan; 41(1):33-9.
    View in: PubMed
    Score: 0.083
  3. Nicolai L, Adornetto R, Bianchini R, Carrer F, Borgo CD, Doro S, Masotti D, Puglisi C, Turini L, Wohlauer M, Galeazzi E. Distal arteriovenous fistula to preserve patency in COVID-19-associated acute limb ischemia. Semin Vasc Surg. 2021 Sep; 34(3):96-100.
    View in: PubMed
    Score: 0.035
  4. Harr JN, Moore EE, Chin TL, Ghasabyan A, Gonzalez E, Wohlauer MV, Banerjee A, Silliman CC, Sauaia A. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg. 2013 Mar; 74(3):756-62; discussion 762-5.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)